Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: By posting the letter after close it rewards longs and hurts day-traders
Pohl continued, "always pointed toward the goal of increasing the financial position and strength of the company and providing value to our shareholders.”

A letter issued by Pohl as CEO of Patriot Scientific is being posted Friday on the Company’s web site at www.ptsc.com. The letter summarizes significant developments of 2006 and provides an update on recent events of interest to shareholders. The company also announced plans to hold an annual shareholders meeting April 27, 2007, in Carlsbad, California. Details will be announced soon and proxy materials will be mailed to shareholders.
Share
New Message
Please login to post a reply